Knollwood Investment Advisory, LLC Repligen Corp Transaction History
Knollwood Investment Advisory, LLC
- $934 Billion
- Q3 2024
A detailed history of Knollwood Investment Advisory, LLC transactions in Repligen Corp stock. As of the latest transaction made, Knollwood Investment Advisory, LLC holds 2,500 shares of RGEN stock, worth $401,275. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$401,275
Previous $315 Million
18.05%
% of portfolio
0.04%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
489Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.21 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.03 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$810 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$261 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$228 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.91B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....